Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus.
Saved in:
| Title: | Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus. |
|---|---|
| Authors: | Zayed M; Access and Value Department, Pfizer Gulf FZ LLC, Dubai, United Arab Emirates., Joury J; Medical Affairs Department, Pfizer Gulf FZ LLC, Dubai, United Arab Emirates., Farghaly M; Health Economics & Insurance Policies Department, Dubai Health Authority, Dubai, United Arab Emirates., Al Dallal S; Strategy and Governance Department, Dubai Health Authority, Dubai, United Arab Emirates., Mahendiran R; Real World Evidence Department, IQVIA, Bengaluru, India., Law AW; HTA, Value & Evidence Department, Pfizer Inc, New York, NY, USA., Mendes D; HTA, Value & Evidence Department, Pfizer Ltd, Tadworth, UK., Quinn E; Avalere Health, Washington, DC, USA., Kutrieb E; Avalere Health, Washington, DC, USA., Averin A; Avalere Health, Washington, DC, USA. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2025 Dec; Vol. 21 (1), pp. 2523106. Date of Electronic Publication: 2025 Jul 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2164-554X |
|---|---|
| DOI: | 10.1080/21645515.2025.2523106 |
